Objective: Prognostic prediction in prenatally diagnosed congenital diaphragmatic hernia (CDH) is needed. The aim of the study was to evaluate magnetic resonance imaging (MRI) signal intensity of the fetal lung as a predictor of prognosis in CDH.
Introduction
Despite significant advances in prenatal diagnosis and neonatal intensive care, mortality rate of neonate prenatally diagnosed congenital diaphragmatic hernia (CDH) still remains unacceptably high, ranging between 20 and 60%.
1-4 Treatment outcome is influenced by pulmonary hypoplasia, pulmonary hypertension, other organ abnormalities and chromosomal abnormalities. The major determinant of survival is the degree of pulmonary hypoplasia if associated defects such as lethal chromosomal abnormalities have been excluded. 5 Therefore, a precise estimation of pulmonary hypoplasia is earnestly needed. However, despite the lack of reliable prognostic parameters to facilitate parental counseling and therapeutic decisions, pregnancy is electively terminated in up to 49% of women in some reports. 5, 6 In addition, fetal surgery has emerged as a therapeutic option and thus has increased the importance of predicting the prognosis during prenatal evaluation. 7 Estimation of pulmonary hypoplasia in prenatally diagnosed CDH has been tried by various methodologies, mainly by ultrasonography and magnetic resonance imaging (MRI). 8 Although the concept of pulmonary hypoplasia consists of growth in total capacity and structural changes, 9 most studies have estimated fetal lung volume quantitatively, but not qualitatively. MRI signal intensity is one of the potential methods to evaluate pulmonary hypoplasia qualitatively. 10 A study of a relatively large series revealed that MRI intensity of the fetuses with severe respiratory disturbance after birth was smaller than that of normal controls.
11
In the present study, we evaluated pulmonary hypoplasia in CDH using MRI signal intensity of the fetal lung standardized by spinal fluid. Obtained parameters were weighed against known quantitative parameters, and were tested for their potential to predict prognoses.
Methods
From August 1997 to July 2007, 15 cases of CDH were diagnosed prenatally and treated after birth in our institution. In these, 14 cases underwent MRI at 29 to 37 weeks of gestation, and clear acceptable images were obtained in 12 cases. In these 12 cases, the clinical charts were retrospectively evaluated.
Assessment of pulmonary hypoplasia
Pulmonary hypoplasia was assessed prenatally by quantitative and qualitative methods. Quantitative evaluation was performed using volumetric measurement by MRI. Qualitative evaluation was performed by measuring signal intensity of the lung by MRI.
MR imaging was performed with a 1.5-T superconducting magnet (Signa; GE Medical Systems, Milwaukee, WI, USA) and a four-element phased-array surface coil (GE Medical Systems).
T2-weighted images were obtained using single-shot rapid acquisition and relaxation enhancement (N/90 (effective)) with a matrix of 256 Â 160-256. A minimal bandwidth was used for all sequences. Acquisition time was 15 to 30 s. Section thickness and intersection gap were 4 to 6 mm and 0 to 1 mm, respectively. T2-weighted images were acquired in transverse, sagittal and coronal planes with respect to the fetal thorax. One reader (HO), who was blinded to any clinical information that might have contributed to selection bias, performed planimetric measurement of lung volumes in all cases according to the methods of Coakley et al. 12 The reader selected images acquired with single-shot rapid acquisition and relaxation enhancement sequences that depicted the complete fields of the both lungs without motion or section misregistration artifacts. The fetal lungs were well depicted at MR imaging and exhibited high signal intensity on T2-weighted images. The cross-sectional area of the lung was measured on each transverse section using a picture archiving and communication system workstation (Advantage Windows RP version 2.0; GE Medical Systems). To calculate the volume for each section, the value of the cross-sectional area was multiplied by that of the section thickness and intersection gap combined. The volumes of all of the sections were then summed to obtain the volume of the entire lung. The volumes of the both lungs were added to obtain the total lung volume. Volumetrically measured values were standardized by values obtained from fetuses with the normal lungs. The best fit for normal lung volume was represented by the regression line V ¼ (2.41 Â G) À37.6 (r ¼ 0.537, P<0.001), in which V is lung volume and G is gestational weeks.
11
Standardized total lung volume is displayed as '%lung volume'.
Qualitative evaluation of the fetal lungs was performed using signal intensity of T2-weighted images. 11 The reader (HO) calculated the ratio of the lung signal intensity to the spinal fluid signal intensity (L/SF) using region-of-interest (ROI) analysis (Figure 1 ). With the same computer program used for image analysis, the mean signal intensity (pixel value) of an ROI that covered the entire cross-sectional area of the contralateral lung on each transverse section was measured. Measurements from a circular ROI of spinal fluid, ranging from 3 to 10 mm 2 , were also obtained; the ROI was placed to include just fluid, and not the spinal cord. For each section, the mean signal intensity of the contralateral lung was divided by that of spinal fluid. This procedure was repeated for all lung sections, and the mean value for the L/SF ratio was obtained. L/SF of normal control is referable in previous paper. 11 Each mother in the study gave informed consent in accordance with a protocol approved by the local institutional review board.
Management
All the patients were treated with the same strategy soon after the birth. The treatment protocol did not include prenatal corticosteroids. All were planned to be delivered by Cesarean section, but two cases underwent emergent Cesarean section because of premature rupture of the membrane. Neonates were intubated in the delivery room and immediately transferred to the intensive-care unit. The first ventilator strategy used was highfrequency oscillation (Humming V; Metran, Kawaguchi, Japan). Sedation was performed mainly by morphine and midazolam, and the use of muscle-paralyzing agents was tried to be minimized. Persistent pulmonary hypertension was evaluated by echocardiography and was managed by prostaglandin E1 and inhaled nitric oxide. Extracorporeal membrane oxygenation was applied in case of failure to respond to conventional therapy. Patients underwent surgical repair only after respiratory and hemodynamic stabilization had been achieved. Exogenous surfactant therapy was applied in all cases. Extubation was performed after appropriate weaning from ventilatory support.
Statistical analysis
All results are expressed as medians with ranges or number of cases. The difference between groups was tested using Student's t-test or the Mann-Whitney U test, depending on normality of the data. Fisher's exact probability test was used for binary variables. Associations were assessed by Spearman's rank correlation and expressed by the corresponding correlation coefficient, rs. The P-values of <0.05 were considered significant.
Results

Treatment outcome
All CDH were unilateral, and 10 cases had left-sided herniation. Associated malformations were omphalocele in one case and cardiac anomalies in three cases, including endocardial cushion defect, coarctation of aorta and ventricular septal defect. In these four cases with severe anomalies, a case with omphalocele and a Prediction of survival prognosis by prenatal and postnatal data Differences between survivors and deaths were assessed by prenatal and postnatal data ( (Figure 2 ). In the postnatal data, only birth weight could predict the survival prognoses (2907 vs 2343 g, P<0.05).
Association between prenatal and postnatal data in survivors Univariate analysis was performed to assess associations between prenatal and postnatal data in survivors. Prenatal data consisted of gestation at diagnosis, total lung volume, contralateral lung volume, %lung volume and L/SF. Postnatal data included birth weight, gestational age, oxygenation index at birth, alveolararterial oxygen tension difference at birth, time between birth and extracorporeal membrane oxygenation, duration of extracorporeal membrane oxygenation, time between birth and surgery and duration of tracheal intubation. Significant associations were detected between gestation at diagnosis and oxygenation index (rs ¼ À0.768, P<0.05), between contralateral lung volume and duration of tracheal intubation (rs ¼ À0.786, P<0.05) and between L/SF and duration of tracheal intubation (rs ¼ À0.938, P<0.01) (Figure 3 ).
Association between L/SF and other prenatal data
Associations between L/SF and other prenatal data, including gestation at diagnosis, gestation at the time of MRI, total lung volume, contralateral lung volume and %lung volume, were assessed. In these parameters, L/SF significantly correlated with contralateral lung volume (rs ¼ 0.684, P<0.05) (Figure 4) 
Discussion
Prediction of survival prognosis of prenatally diagnosed CDH has been aggressively attempted using prenatal data including gestation at diagnosis and imaging method for lung parenchyma, pulmonary blood vessel and position of exposed viscera. 8 In these prenatal factors, assessment of pulmonary hypoplasia is one of the most important aspects to determine therapeutic strategy of prenatally diagnosed CDH. However, it is difficult to predict prognosis by quantitative pulmonary evaluation alone because of two problems. First, the increase of lung volumes is too small to evaluate differences, in gestational weeks between 20 and 25, when prenatal counseling and decision making for pulmonary hypoplasia is crucially needed. Second, lung volumes change with too much variance after the gestational week 31. 13 Furthermore, although lung-to-head ratio (LHR) is a prominent parameter to predict the prognoses of CDH, a significant number of cases exist in the narrow range between 1.0 and 1.4 exactly. 10, 14 Therefore, LHR is used as a prognostic marker combined with the location of the liver. 15 In Japan, systematic fetal screening has not been established; therefore, gestation at diagnosis of CDH tends to be late, resulting in delay in assessing LHR. LHR is thought to be only useful as a prognostic marker if measured between 23 and 27 weeks of gestation, 15 because normal lungs increase in size four times more than the head circumference. 16 In the present study, the measurements of LHR were performed after 29 weeks of gestation except a case, and hence estimation of pulmonary hypoplasia by LHR could not be used. Although expected LHR standardized by that of normal fetal lung has been developed by Deprest and colleagues, 15 it is not corresponding to LHR measured after 32 weeks of gestation.
In the present study, parameters for lung volume and L/SF could predict the survival prognoses of CDH. The former is quantitative and the latter is qualitative in the MRI evaluation of fetal lung. Radical different point between these two factors is that whereas contralateral lung volume correlated with gestation at the time of MRI, L/SF did not. The larger study also showed the same result in either healthy or ill fetuses.
11 L/SF correlated with lung volume instead. Therefore, whereas lung volume is influenced by gestation at examination, L/SF is simply affected by lung volume, not by gestation in weeks. On that point, L/SF may be a method unconstrained by gestation at measurement compared with volumetric estimation. This characteristic may provide several important benefits for comparing a number of cases and assessing their grade of severity. Although the result of the analysis of receiver operating characteristic curve was not significant (data not shown), L/SF has a chance to be more precise predictor by combining with volumetric estimation. Furthermore, contralateral lung volume and L/SF are also associated with duration of tracheal intubation in survivors. This suggests that these two factors are not only a useful prognostic predictor, but also an indicator of the degree of pulmonary hypoplasia.
Low MRI intensity in T2-weighted image is thought to be a sign of pulmonary hypoplasia clinically, 17, 18 and animal study also showed it. 19 However, the meaning of MRI signal intensity of the CDH lung remains controversial. 13 Factors that influence MRI intensity of fetal lung have been explained as follows. Secretion of lung fluid in future airspace results in an accumulation of free protons and the decrease of the water binding hyaluronic acid fraction, which could be responsible for the changing appearance on T2-weighted sequences. 11, 20, 21 Furthermore, the production of surfactant and surfactant proteins may have an impact on MR signal properties, especially after gestational week 30. 22, 23 Although the pathogenesis of pulmonary hypoplasia in CDH remains poorly understood, the fetal lung fluid has a key role in normal lung development as is mentioned. 24, 25 Recent studies using MRI signal intensity for fetuses with CDH showed both positive 26 and negative 27, 28 data for prediction of survival prognosis. In the quantitative analysis of MR images, measured values of MRI intensity is not absolutes, and therefore cannot to be used for direct comparison of multiple examinations. 29 To standardize lung signal intensity, various organs such as spinal fluid, 11 liver 18,30 and muscle 31 have been used. We chosen the spinal fluid as the reference for the following reasons: (1) the spinal canal exists close to the lung, and in every transverse section of the lung; (2) the spinal fluid signal intensity is high, which reduces random error attributable to noise in the calculation of the final ratio; and (3) the spinal fluid signal intensity is not expected to change with increasing gestation time, 11 whereas liver intensity changes. 29 A limitation of this study is the relatively small number of patients. This retrospective preliminary report indicated that further large studies are still necessary to elucidate the efficacy of MRI signal intensity for estimation of the fetal lung in CDH patients.
In summary, L/SF is a unique factor to predict the survival prognosis and likely to quantify the degree of pulmonary hypoplasia in CDH. L/SF has a chance to be a more precise predictor by combining with volumetric methodology, and to contribute to parental counseling and decision making on therapeutic strategy for CDH patients.
